Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -170,874 | -123,214 | -68,151 | -129,874 | -84,089 |
| Depreciation Amortization | -8,051 | -5,647 | -2,870 | 45 | 961 |
| Accounts payable and accrued liabilities | -10,524 | -10,416 | -6,647 | 11,524 | 9,779 |
| Other Working Capital | -15,041 | -10,958 | -6,263 | 15,962 | 8,705 |
| Other Operating Activity | 58,320 | 43,048 | 21,958 | 8,505 | 4,848 |
| Operating Cash Flow | $-146,170 | $-107,187 | $-61,973 | $-93,838 | $-59,796 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 76,309 | 27,864 | -13,180 | -114,329 | 66,043 |
| PPE Investments | -850 | -446 | -115 | -797 | -566 |
| Investing Cash Flow | $75,459 | $27,418 | $-13,295 | $-115,126 | $65,477 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | N/A | N/A | 5,000 | 4,554 |
| Common Stock Issued | 12,243 | 11,272 | 8,204 | 295,754 | 268,814 |
| Other Financing Activity | -514 | 0 | 0 | 21,490 | 22,862 |
| Financing Cash Flow | $26,729 | $11,272 | $8,204 | $322,244 | $296,230 |
| Beginning Cash Position | 155,579 | 155,579 | 155,579 | 42,299 | 42,299 |
| End Cash Position | 111,597 | 87,082 | 88,515 | 155,579 | 344,210 |
| Net Cash Flow | $-43,982 | $-68,497 | $-67,064 | $113,280 | $301,911 |
| Free Cash Flow | |||||
| Operating Cash Flow | -146,170 | -107,187 | -61,973 | -93,838 | -59,796 |
| Capital Expenditure | -850 | -446 | -115 | -797 | -566 |
| Free Cash Flow | -147,020 | -107,633 | -62,088 | -94,635 | -60,362 |